Basilea Pharmaceutica Ltd (PK5)
Market Closed
19 Jun, 20:00
XSTU 
€
54. 90
0
0%
€
- Market Cap
7.96 P/E Ratio
20% Div Yield
278 Volume
2.9 Eps
€ 54.9
Previous Close Want to track PK5 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
PK5 Earnings Reports FAQ
What is the earnings per share (EPS) for PK5?
The current EPS is 2.9.
What is the company's earnings growth rate?
Basilea Pharmaceutica Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Basilea Pharmaceutica Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Basilea Pharmaceutica Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for PK5 at this time, as Basilea Pharmaceutica Ltd has no recent EPS data to calculate it.
